Updates on the management of neurocysticercosis

A. Clinton White, Hector H. Garcia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

PURPOSE OF REVIEW: The goal of this review is highlight recent developments regarding neurocysticercosis, including recently developed guidelines. RECENT FINDINGS: Recent diagnostic criteria highlight the importance of neuroimaging in establishing a diagnosis. Monoclonal antibody-based antigen detection and the enzyme-linked immunotransfer blot can be confirmatory. Management should be guided by the form of disease. Single enhancing lesions and one to two viable parenchymal cysticerci can be treated with short courses of albendazole and corticosteroid. Multiple parenchymal lesions should be treated with the combination of corticosteroids, albendazole, and praziquantel. Ventricular cysticerci should be removed when possible, often by minimally invasive surgery. Subarachnoid cysticercosis often requires prolonged courses of antiparasitic and anti-inflammatory treatment. SUMMARY: Neurocysticerocis represents a spectrum of disease that is a common cause of neurologic disease worldwide. Management needs to be guided by the number and location of the parasites and the host response.

Original languageEnglish (US)
Pages (from-to)377-382
Number of pages6
JournalCurrent opinion in infectious diseases
Volume31
Issue number5
DOIs
StatePublished - Oct 1 2018

Fingerprint

Cysticercus
Neurocysticercosis
Albendazole
Adrenal Cortex Hormones
Antiparasitic Agents
Cysticercosis
Praziquantel
Minimally Invasive Surgical Procedures
Nervous System Diseases
Neuroimaging
Parasites
Anti-Inflammatory Agents
Monoclonal Antibodies
Guidelines
Antigens
Enzymes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Updates on the management of neurocysticercosis. / White, A. Clinton; Garcia, Hector H.

In: Current opinion in infectious diseases, Vol. 31, No. 5, 01.10.2018, p. 377-382.

Research output: Contribution to journalArticle

@article{cc619f6298e34d79b1c3bd1d0dacaf6b,
title = "Updates on the management of neurocysticercosis",
abstract = "PURPOSE OF REVIEW: The goal of this review is highlight recent developments regarding neurocysticercosis, including recently developed guidelines. RECENT FINDINGS: Recent diagnostic criteria highlight the importance of neuroimaging in establishing a diagnosis. Monoclonal antibody-based antigen detection and the enzyme-linked immunotransfer blot can be confirmatory. Management should be guided by the form of disease. Single enhancing lesions and one to two viable parenchymal cysticerci can be treated with short courses of albendazole and corticosteroid. Multiple parenchymal lesions should be treated with the combination of corticosteroids, albendazole, and praziquantel. Ventricular cysticerci should be removed when possible, often by minimally invasive surgery. Subarachnoid cysticercosis often requires prolonged courses of antiparasitic and anti-inflammatory treatment. SUMMARY: Neurocysticerocis represents a spectrum of disease that is a common cause of neurologic disease worldwide. Management needs to be guided by the number and location of the parasites and the host response.",
author = "White, {A. Clinton} and Garcia, {Hector H.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1097/QCO.0000000000000480",
language = "English (US)",
volume = "31",
pages = "377--382",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Updates on the management of neurocysticercosis

AU - White, A. Clinton

AU - Garcia, Hector H.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - PURPOSE OF REVIEW: The goal of this review is highlight recent developments regarding neurocysticercosis, including recently developed guidelines. RECENT FINDINGS: Recent diagnostic criteria highlight the importance of neuroimaging in establishing a diagnosis. Monoclonal antibody-based antigen detection and the enzyme-linked immunotransfer blot can be confirmatory. Management should be guided by the form of disease. Single enhancing lesions and one to two viable parenchymal cysticerci can be treated with short courses of albendazole and corticosteroid. Multiple parenchymal lesions should be treated with the combination of corticosteroids, albendazole, and praziquantel. Ventricular cysticerci should be removed when possible, often by minimally invasive surgery. Subarachnoid cysticercosis often requires prolonged courses of antiparasitic and anti-inflammatory treatment. SUMMARY: Neurocysticerocis represents a spectrum of disease that is a common cause of neurologic disease worldwide. Management needs to be guided by the number and location of the parasites and the host response.

AB - PURPOSE OF REVIEW: The goal of this review is highlight recent developments regarding neurocysticercosis, including recently developed guidelines. RECENT FINDINGS: Recent diagnostic criteria highlight the importance of neuroimaging in establishing a diagnosis. Monoclonal antibody-based antigen detection and the enzyme-linked immunotransfer blot can be confirmatory. Management should be guided by the form of disease. Single enhancing lesions and one to two viable parenchymal cysticerci can be treated with short courses of albendazole and corticosteroid. Multiple parenchymal lesions should be treated with the combination of corticosteroids, albendazole, and praziquantel. Ventricular cysticerci should be removed when possible, often by minimally invasive surgery. Subarachnoid cysticercosis often requires prolonged courses of antiparasitic and anti-inflammatory treatment. SUMMARY: Neurocysticerocis represents a spectrum of disease that is a common cause of neurologic disease worldwide. Management needs to be guided by the number and location of the parasites and the host response.

UR - http://www.scopus.com/inward/record.url?scp=85063860326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063860326&partnerID=8YFLogxK

U2 - 10.1097/QCO.0000000000000480

DO - 10.1097/QCO.0000000000000480

M3 - Article

VL - 31

SP - 377

EP - 382

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 5

ER -